Eye-Tracking tech could spot macular degeneration faster

NCT ID NCT06518512

Ongoing Diagnosis Sponsor: Tan Tock Seng Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called AVIGA that tracks eye movements to detect vision problems in people with wet age-related macular degeneration (AMD). Researchers will compare the device's results with standard eye exams to see if it can reliably spot disease activity. The goal is to develop a quick, automated way to monitor AMD over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system
What this could lead to: If successful, this could lead to a simple, automated eye-tracking test to detect and monitor wet age-related macular degeneration without the need for complex equipment.
What could go wrong: This is an early-stage study with 128 participants, so results may not apply to everyone. The device is not yet proven to replace standard tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration macular degeneration wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

Tan Tock Seng Hospital

Singapore, 308433, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.